home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

67.86 +0.99 (+1.48%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Where Twist Bioscience Stands With Analysts ↗

October 06, 2022

Over the past 3 months, 4 analysts have published their opinion on Twist Bioscience (NASDAQ:TWST) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Twist Bioscience to Present at JSNN NanoImpacts 2022

October 05, 2022

From Twist Bioscience Corporation

Via Business Wire

FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests ↗

September 27, 2022

Via Benzinga

Twist Bioscience Q3 Sales Jump 60%, Raises FY22 Revenue Outlook Surpassing Consensus ↗

August 05, 2022

Via Benzinga

Recap: Twist Bioscience Q3 Earnings ↗

August 05, 2022

Twist Bioscience (NASDAQ:TWST) reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls For Developing Assays ↗

July 14, 2022

Via Benzinga

COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns ↗

September 23, 2022

The World Health Organization (WHO) warned that it struggles to identify and

Via Benzinga

The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia

September 20, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Present at Baird 2022 Global Healthcare Conference

September 06, 2022

From Twist Bioscience Corporation

Via Business Wire

Catalent, Tellurian And Other Big Losers From Monday ↗

August 30, 2022

U.S. stocks closed lower with the Dow Jones dropping around 185 points on Monday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

No More Free COVID-19 At-Home Tests, Federal Government Says ↗

August 29, 2022

CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au

Via Benzinga

Block To $130? Plus Oppenheimer Predicts $11 For GoPro ↗

August 08, 2022

Oppenheimer cut the price target for GoPro, Inc. (NASDAQ: GPRO) from $12 to $11. GoPro shares rose 1.2% to $6.64 in pre-market trading.

Via Benzinga

Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday ↗

August 10, 2022

U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday ↗

August 08, 2022

U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday ↗

August 08, 2022

Gainers

Via Benzinga

Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results

August 05, 2022

From Twist Bioscience Corporation

Via Business Wire

Earnings Scheduled For August 5, 2022 ↗

August 05, 2022

Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.

Via Benzinga

Twist Bioscience Earnings Preview ↗

August 04, 2022

Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Twist...

Via Benzinga

Twist Bioscience to Present at Flash Memory Summit

August 03, 2022

From Twist Bioscience Corporation

Via Business Wire

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 02, 2022

Via Benzinga

Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market

August 02, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2

August 02, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit

August 01, 2022

From Twist Bioscience Corporation

Via Business Wire

5 Top Stocks Cathie Wood Bought This Week ↗

July 21, 2022

Shares of ARKK are up about 20% the past month as Cathie Wood continues her highly-convicted purchases of growth stocks.

Via InvestorPlace

Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022

July 18, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls

July 14, 2022

From Twist Bioscience Corporation

Via Business Wire

DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow

July 13, 2022

From DNAnexus, Inc.

Via Business Wire

7 Best Biotech Stocks to Buy in July 2022 ↗

July 08, 2022

The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict.

Via InvestorPlace

Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity

July 06, 2022

From Twist Bioscience Corporation

Via Business Wire

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com